ID   Me665/1
AC   CVCL_C667
SY   Me 665/1; 665/1; INT-MEL-60/1
DR   Wikidata; Q54904976
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=2469723;
RX   PubMed=2776368;
RX   PubMed=8459226;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7077 ! Me665/2
OI   CVCL_HE41 ! Me665/3
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
RX   DOI=10.1007/0-306-46872-7_16;
RA   Anichini A., Mortarini R., Vegetti C., Molla A., Borri A., Parmiani G.;
RT   "Melanoma: the Milan melanoma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.283-292; Kluwer Academic Publishers; New York; USA (1999).
//
RX   PubMed=2469723; DOI=10.4049/jimmunol.142.10.3692;
RA   Anichini A., Mazzocchi A., Fossati G., Parmiani G.;
RT   "Cytotoxic T lymphocyte clones from peripheral blood and from tumor
RT   site detect intratumor heterogeneity of melanoma cells. Analysis of
RT   specificity and mechanisms of interaction.";
RL   J. Immunol. 142:3692-3701(1989).
//
RX   PubMed=2776368; DOI=10.1007/BF01753674;
RA   Larizza L., Doneda L., Rodolfo M., Fossati G.;
RT   "High incidence of chromosomal lesions involving C-heterochromatin in
RT   four human melanoma lines.";
RL   Clin. Exp. Metastasis 7:633-644(1989).
//
RX   PubMed=8459226; DOI=10.1084/jem.177.4.989; PMCID=PMC2190978;
RA   Anichini A., Maccalli C., Mortarini R., Salvi S., Mazzocchi A.,
RA   Squarcina P., Herlyn M., Parmiani G.;
RT   "Melanoma cells and normal melanocytes share antigens recognized by
RT   HLA-A2-restricted cytotoxic T cell clones from melanoma patients.";
RL   J. Exp. Med. 177:989-998(1993).
//